Does ivermectin have a place in the treatment of mild Covid-19?

Eli Schwartz

doi:10.1016/j.nmni.2022.100985

Does ivermectin have a place in the treatment of mild Covid-19?

Eli Schwartz

Clinical Departments

Research output: Contribution to journal › Editorial

5 Scopus citations

Original language	English
Article number	100985
Journal	New Microbes and New Infections
Volume	46
DOIs	https://doi.org/10.1016/j.nmni.2022.100985
State	Published - Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Coronavirus treatment
SARS-CoV-2
hospitalization
molnupiravir, paxlovid

Access to Document

10.1016/j.nmni.2022.100985

Cite this

@article{c77872ff31de47c68ca565a83359749f,

title = "Does ivermectin have a place in the treatment of mild Covid-19?",

keywords = "Coronavirus treatment, SARS-CoV-2, hospitalization, molnupiravir, paxlovid",

author = "Eli Schwartz",

year = "2022",

month = mar,

doi = "10.1016/j.nmni.2022.100985",

language = "אנגלית",

volume = "46",

journal = "New Microbes and New Infections",